Quantitative evaluation of scintillation camera imaging characteristics of isotopes used in liver radioembolization

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Elschot, Mattijs ^a   Nijsen, Johannes Franciscus Wilhelmus ^a   Dam, Alida Johanna ^a,b   de Jong, Hugo Wilhelmus Antonius Maria ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b GELRE HOSPITALS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HOLMIUM; TECHNETIUM 99M; YTTRIUM 90; ISOTOPE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; ARTIFICIAL EMBOLISM; COLLIMATOR; CONTROLLED STUDY; DOSIMETRY; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; LIGHT SCATTERING; MONTE CARLO METHOD; PHANTOM; PRACTICE GUIDELINE; QUANTITATIVE ANALYSIS; SCINTILLATION CAMERA; SENSITIVITY ANALYSIS; HUMAN; LIVER; METABOLISM;

EMBOLIZATION, THERAPEUTIC; GAMMA CAMERAS; HUMANS; ISOTOPES; LIVER; MONTE CARLO METHOD; PHANTOMS, IMAGING; RADIOPHARMACEUTICALS;

EID: 80455158116     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026174     Document Type: Article

References (40)

1. Kennedy AS, Salem R, (2010) Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies. Cancer J 16: 163-175.
2. Vente MA, Wondergem M, van der Tweel I, van den Bosch MA, Zonnenberg BA, et al. (2009) Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 19: 951-959.
3. Gulec SA, Fong Y, (2007) Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases. Arch Surg 142: 675-682.
4. Fabbri C, Sarti G, Cremonesi M, Ferrari M, Di DA, et al. (2009) Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry. Cancer Biother Radiopharm 24: 145-154.
5. Minarik D, Sjogreen GK, Ljungberg M, (2008) Evaluation of quantitative (90)Y SPECT based on experimental phantom studies. Phys Med Biol 53: 5689-5703.
6. Minarik D, Ljungberg M, Segars P, Gleisner KS, (2009) Evaluation of quantitative planar 90Y bremsstrahlung whole-body imaging. Phys Med Biol 54: 5873-5883.
7. Shen S, DeNardo GL, Yuan A, DeNardo DA, DeNardo SJ, (1994) Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung. J Nucl Med 35: 1381-1389.
8. Ho S, Lau WY, Leung TW, Chan M, Chan KW, et al. (1997) Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin. Br J Radiol 70: 823-828.
9. Ho S, Lau WY, Leung TW, Chan M, Johnson PJ, et al. (1997) Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 24: 293-298.
10. Bult W, Vente MAD, Zonnenberg BA, van het Schip AD, Nijsen JFW, (2009) Microsphere, radioembolization of liver malignancies: current developments. Quarterly Journal of Nuclear Medicine and Molecular Imaging 53: 325-335.
11. Koch W, Tatsch K, (2008) Nuclear medicine procedures for treatment evaluation. In: Bilbao JI, Reiser MF, editors. Liver radioembolization with 90Y microspheres Heidelberg Springer pp. 75-91.
12. Sabet A, Ahmadzadehfar H, Muckle M, Haslerud T, Wilhelm K, et al. (2011) Significance of Oral Administration of Sodium Perchlorate in Planning Liver-Directed Radioembolization. Journal of Nuclear Medicine 52: 1063-1067.
13. Salem R, Parikh P, Atassi B, Lewandowski RJ, Ryu RK, et al. (2008) Incidence of Radiation Pneumonitis After Hepatic Intra-Arterial Radiotherapy With Yttrium-90 Microspheres Assuming Uniform Lung Distribution. American Journal of Clinical Oncology-Cancer Clinical Trials 31: 431-438.
14. Nijsen JF, Zonnenberg BA, Woittiez JR, Rook DW, Swildens-van Woudenberg IA, et al. (1999) Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques. Eur J Nucl Med 26: 699-704.
15. Nijsen JF, Seppenwoolde JH, Havenith T, Bos C, Bakker CJ, et al. (2004) Liver tumors: MR imaging of radioactive holmium microspheres-phantom and rabbit study. Radiology 231: 491-499.
16. Smits MLJ, Nijsen JFW, van den Bosch MAAJ, Lam MGEH, Vente MAD, et al. (2010) Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial. Journal of Experimental & Clinical Cancer Research 29.
17. Vente MA, Nijsen JF, de Wit TC, Seppenwoolde JH, Krijger GC, et al. (2008) Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs. Eur J Nucl Med Mol Imaging 35: 1259-1271.
18. Vente MA, de Wit TC, van den Bosch MA, Bult W, Seevinck PR, et al. (2010) Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model. Eur Radiol 20: 862-869.
19. Bayouth JE, Macey DJ, (1994) Quantitative imaging of holmium-166 with an Anger camera. Phys Med Biol 39: 265-279.
20. de Wit TC, Xiao J, Nijsen JF, van het Schip FD, Staelens SG, et al. (2006) Hybrid scatter correction applied to quantitative holmium-166 SPECT. Phys Med Biol 51: 4773-4787.
21. National Electrical Manufacturers Association (2007) NEMA Standards Publication NU 1-2007: Performance Measurements of Gamma Cameras Rosslyn, VA National Electrical Manufacturers Association.
22. National Electrical Manufacturers Association (2007) NEMA Standards Publication NU 2-2007: Performance Measurements of Positron Emission Tomographs Rosslyn, VA National Electrical Manufacturers Association.
23. Knesaurek K, Machac J, Muzinic M, DaCosta M, Zhang Z, et al. (2010) Quantitative comparison of yttrium-90 (90Y)-microspheres and technetium-99m (99mTc)-macroaggregated albumin SPECT images for planning 90Y therapy of liver cancer. Technol Cancer Res Treat 9: 253-262.
24. Mansberg R, Sorensen N, Mansberg V, Van der Wall H, (2007) Yttrium 90 Bremsstrahlung SPECT/CT scan demonstrating areas of tracer/tumour uptake. Eur J Nucl Med Mol Imaging 34: 1887.
25. Clarke LP, Cullom SJ, Shaw R, Reece C, Penney BC, et al. (1992) Bremsstrahlung Imaging Using the Gamma-Camera- Factors Affecting Attenuation. Journal of Nuclear Medicine 33: 161-166.
26. Flamen P, Vanderlinden B, Delatte P, Ghanem G, Ameye L, et al. (2008) Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres. Phys Med Biol 53: 6591-6603.
27. Ito S, Kurosawa H, Kasahara H, Teraoka S, Ariga E, et al. (2009) (90)Y bremsstrahlung emission computed tomography using gamma cameras. Annals of Nuclear Medicine 23: 257-267.
28. Sorensen JA, (1975) Deadtime characteristics of anger cameras. J Nucl Med 16: 284-288.
29. Hendricks JS, McKinney GW, Waters LS, Roberts TS, Egdorf HW, et al. (2005) MCNPX Extensions, Version 2.5.0 Los Alamos, CA Los Alamos National Laboratory Report LA-UR-05-2675.
30. Rault E, Staelens S, Van Holen R, De Beenhouwer J, Vandenberghe S, (2010) Fast simulation of yttrium-90 bremsstrahlung photons with GATE. Med Phys 37: 2943-2950.
31. Da Silva AJ, Tang HR, Wong KH, Wu MC, Dae MW, et al. (2001) Absolute Quantification of Regional Myocardial Uptake of 99mTc-Sestamibi with SPECT: Experimental Validation in a Porcine Model. J Nucl Med 42: 772-779.
32. Shcherbinin S, Celler A, Belhocine T, Vanderwerf R, Driedger A, (2008) Accuracy of quantitative reconstructions in SPECT/CT imaging. Physics in Medicine and Biology 53: 4595-4604.
33. Vandervoort E, Celler A, Harrop R, (2007) Implementation of an iterative scatter correction, the influence of attenuation map quality and their effect on absolute quantitation in SPECT. Physics in Medicine and Biology 52: 1527-1545.
34. Zeintl J, Vija AH, Yahil A, Hornegger J, Kuwert T, (2010) Quantitative Accuracy of Clinical 99mTc SPECT/CT Using Ordered-Subset Expectation Maximization with 3-Dimensional Resolution Recovery, Attenuation, and Scatter Correction. J Nucl Med 51: 921-928.
35. Gates VL, Esmail AAH, Marshall K, Spies S, Salem R, (2011) Internal Pair Production of (90)Y Permits Hepatic Localization of Microspheres Using Routine PET: Proof of Concept. Journal of Nuclear Medicine 52: 72-76.
36. Walrand S, Jamar F, van Elmbt L, Lhommel R, Bekonde EB, et al. (2010) 4-Step Renal Dosimetry Dependent on Cortex Geometry Applied to (90)Y Peptide Receptor Radiotherapy: Evaluation Using a Fillable Kidney Phantom Imaged by (90)Y PET. Journal of Nuclear Medicine 51: 1969-1973.
37. Lhommel R, van Elmbt L, Goffette P, Van den Eynde M, Jamar F, et al. (2010) Feasibility of (90)Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres. European Journal of Nuclear Medicine and Molecular Imaging 37: 1654-1662.
38. Lhommel R, Goffette P, Van den Eynde M, Jamar F, Pauwels S, et al. (2009) Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT. European Journal of Nuclear Medicine and Molecular Imaging 36: 1696-1696.
39. Seevinck PR, Seppenwoolde JH, Zwanenburg JJ, Nijsen JF, Bakker CJ, (2008) FID sampling superior to spin-echo sampling for T2*-based quantification of holmium-loaded microspheres: theory and experiment. Magn Reson Med 60: 1466-1476.
40. Seppenwoolde JH, Nijsen JF, Bartels LW, Zielhuis SW, van het Schip AD, et al. (2005) Internal radiation therapy of liver tumors: qualitative and quantitative magnetic resonance imaging of the biodistribution of holmium-loaded microspheres in animal models. Magn Reson Med 53: 76-84.